Northwell Health Appoints Brian S. Kim as First Chief Biotechnology Officer

{
  "signal_id": "a640d4a1-cf2b-27a6-25ad-d5b066604674",
  "signal_type": "news",
  "signal_subtype": "hires",
  "detected_at": "2026-07-06T16:58:26+00:00",
  "company": {
    "name": "Northwell Health",
    "domain": "northwell.edu"
  },
  "data": {
    "url": "https://www.citybiz.co/article/870150/northwell-health-appoints-brian-s-kim-as-first-chief-biotechnology-officer/",
    "title": "Northwell Health Appoints Brian S. Kim as First Chief Biotechnology Officer - citybiz",
    "contact": "Brian S. Kim",
    "excerpt": "Northwell Health has named renowned physician-scientist Brian S. Kim, MD, MTR , as its first chief biotechnology officer, creating a new executive role aimed at accelerating the commercialization of research emerging from The Feinstein Institutes for Medical Research. Kim also joins as vice president and chief biotechnology officer at Northwell, head of intellectual asset management at the Feinstein Institutes, and the inaugural Robin and Jack Ross Chair in Bioelectronic Medicine and Neuroimmunology. Based at the Feinstein Institutes, Northwell’s research organization, Kim will oversee biotechnology strategy and intellectual property management while helping advance discoveries in bioelectronic medicine and neuroimmunology from laboratory research into clinical applications. He will also serve as a professor in the Institute of Bioelectronic Medicine and hold a faculty appointment in Northwell Health’s Department of Dermatology. Kim joins Northwell from the Icahn School of Medicine at Mount Sinai, where he built an internationally recognized career as a dermatologist and physician-scientist. He has authored more than 190 peer-reviewed publications in journals including Cell , Nature , Science , The New England Journal of Medicine and JAMA , and has maintained continuous National Institutes of Health funding since 2011. He also leads the Allen Discovery Center for Neuroimmune...",
    "summary": "Northwell Health has hired Dr. Brian S. Kim as its first Chief Biotechnology Officer to accelerate the commercialization of research from The Feinstein Institutes for Medical Research.",
    "planning": false,
    "job_title": "Chief Biotechnology Officer",
    "confidence": 0.95,
    "published_at": "2026-07-06T16:58:26Z",
    "job_title_tags": [
      "directors",
      "general_technology"
    ],
    "article_sentence": "Kim, MD, MTR , as its first chief biotechnology officer, creating a new executive role aimed at accelerating the commercialization of research emerging from The Feinstein Institutes for Medical Research."
  }
}

curl https://signals.autobound.ai/v1/signals/a640d4a1-cf2b-27a6-25ad-d5b066604674 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"northwell.edu","limit":20}'